APAC Pingueculum Drugs Market - Industry Trends and Forecast to 2029

Description

List of Tables

The Asia-Pacific pingueculum drugs market is projected to register a substantial CAGR of 8.5% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.

Market Segmentation:

Asia-Pacific Pingueculum Drugs Market, By Treatment (Artificial Tears /Topical Lubricants, Steroid Eye Drops, Non-steroidal Anti Inflammatory Drops, and Others), Formulation Type (Eye Drops, Eye Ointments, and Others), Mode of Purchase (Prescription, Over the Counter), Drug Type (Branded, Generics), Population Type (Geriatric, Adults), End User (Hospitals, Speciality Clinics, Home Healthcare, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, and Rest of the Asia-Pacific) Industry Trends and Forecast to 2029.

Some of the major factors contributing to the growth of the Asia-Pacific pingueculum drugs market are:

Rise in the UV exposure to the individuals due to ozone defect casing pingueculum more frequently

Rising awareness among people for eye-related diseases

Market Players:

Some of the major players operating in the Asia-Pacific pingueculum drugs market are:

Abbvie Inc.

Alcon Inc.

Amneal Pharmaceuticals LLC

Bausch & Lomb Incorporated

Bayer AG

EYERIS VISIONCARE Pvt. Ltd.

Johnson & Johnson Consumer Inc.

Maya Biotech Private Limited

Novartis AG

OASIS Medical, Inc.

Santen Pharmaceutical Co.

Spectra Vision Care

Laboratoires Thea

Wellona Pharma

Zydus Group

Prestige Consumer Healthcare Inc.

Johnson & Johnson Vision Care, Inc.

1 INTRODUCTION 43

1.1 OBJECTIVES OF THE STUDY 43
1.2 MARKET DEFINITION 43
1.3 OVERVIEW OF THE ASIA PACIFIC PINGUECULUM DRUGS MARKET 43
1.4 CURRENCY AND PRICING 45
1.5 LIMITATIONS 45
1.6 MARKETS COVERED 46

2 ASIA PACIFIC PINGUECULUM DRUGS MARKET: SEGMENTATION 48

2.1 MARKETS COVERED 48
2.2 GEOGRAPHICAL SCOPE 49
2.3 YEARS CONSIDERED FOR THE STUDY 50
2.4 CURRENCY AND PRICING 50
2.5 DBMR TRIPOD DATA VALIDATION MODEL 51
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 54
2.7 MULTIVARIATE MODELLING 55
2.8 TREATMENT LIFELINE CURVE 55
2.9 DBMR MARKET POSITION GRID 56
2.10 VENDOR SHARE ANALYSIS 58
2.11 MARKET END-USER COVERAGE GRID 59
2.12 SECONDARY SOURCES 60
2.13 ASSUMPTIONS 60

3 EXECUTIVE SUMMARY 61

4 PREMIUM INSIGHTS 64

4.1 EPIDERMIOLOGY 65
4.2 PESTEL ANALYSIS 66
4.3 PORTER'S FIVE FORCES 67
4.4 PIPELINE ANALYSIS FOR THE ASIA PACIFIC PINGUECULUM DRUGS MARKET 68
4.5 INDUSTRIAL INSIGHTS: 69
4.6 CONCLUSION: 69

5 ASIA PACIFIC PINGUECULUM DRUGS MARKET: REGULATIONS 70

6 MARKET OVERVIEW 73

6.1 DRIVERS 75
- 6.1.1 RISING PREVALENCE OF PINGUECELA DISORDERS AND OCULAR PAINS 75
- 6.1.2 RISE IN THE CHRONIC UV RADIATION EXPOSURE DUE TO OZONE DEFECT 75
- 6.1.3 INCREASING AWARENESS AMONG PEOPLE FOR EYE-RELATED DISEASES 76
- 6.1.4 RISING OPHTHALMIC EMERGENCIES IN THE GERIATRIC PATIENT 77
6.2 RESTRAINTS 77
- 6.2.1 STRINGENT RULES & REGULATIONS 77
- 6.2.2 LACK OF HEALTHCARE FACILITIES FOR EYE TREATMENT 78
6.3 OPPORTUNITIES 79
- 6.3.1 INITIATIVES AND PLANS TO LESSEN THE PREVALENCE OF EYE ILLNESSES 79
- 6.3.2 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES 79
- 6.3.3 INCREASE IN HEALTHCARE SPENDING AND ACCESSIBLE INCOME 80
6.4 CHALLENGES 81
- 6.4.1 ADVERSE EFFECTS OF STEROID EYE DROPS 81
- 6.4.2 LACK OF SKILLED OPHTHALMOLOGISTS 82

7 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY TREATMENT 83

7.1 OVERVIEW 84
7.2 ARTIFICIAL TEARS/TOPICAL LUBRICANTS 87
- 7.2.1 DEMULCENT 87
- 7.2.2 EMOLLIENTS 87
7.3 STEROID EYE DROPS 88
- 7.3.1 KETONE STEROIDS 89
  - 7.3.1.1 PREDNISOLONE 89
  - 7.3.1.2 DEXAMETHASONE 89
  - 7.3.1.3 FLUROMETHOLONE 89
  - 7.3.1.4 MEDRYSONE 89
  - 7.3.1.5 RIMEXOLONE 89
  - 7.3.1.6 OTHERS 89
- 7.3.2 ESTER STEROID (LOTERPREDNOL) 90
7.4 NON-STEROIDAL ANTI-INFLAMMATORY DROPS 90
7.5 OTHERS 90

8 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY FORMULATION 91

8.1 OVERVIEW 92
8.2 EYE DROPS 95
- 8.2.1 EYE DROPS WITH PRESERVATIVES 95
- 8.2.2 PRESERVATIVE-FREE EYE DROPS 95
8.3 EYE OINTMENTS 96
- 8.3.1 WITH PRESERVATIVES 96
- 8.3.2 PRESERVATIVE-FREE 96
- 8.3.3 OTHERS 96
8.4 OTHERS 97

9 ASIA PACIFIC PINGUECULUM DRUGS MARKET, MODE OF PURCHASE 98

9.1 OVERVIEW 99
9.2 PRESCRIPTION 102
9.3 OVER THE COUNTER (OTC) 102

10 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY DRUGS TYPE 103

10.1 OVERVIEW 104
10.2 BRANDED 107
10.3 GENERICS 107

11 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY POPULATION TYPE 108

11.1 OVERVIEW 109
11.2 GERIATRIC 112
- 11.2.1 MALE 112
- 11.2.2 FEMALE 112
11.3 ADULTS 113
- 11.3.1 MALE 113
- 11.3.2 FEMALE 113

12 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY END USER 114

12.1 OVERVIEW 115
12.2 HOSPITALS 118
12.3 SPECIALTY CLINICS 118
12.4 HOME HEALTHCARE 119
12.5 OTHERS 119

13 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL 120

13.1 OVERVIEW 121
13.2 RETAIL PHARMACIES 124
13.3 HOSPITAL PHARMACIES 124
13.4 ONLINE PHARMACIES 125
13.5 OTHERS 125

14 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY REGION 126

14.1 ASIA-PACIFIC 127
- 14.1.1 CHINA 137
- 14.1.2 INDIA 141
- 14.1.3 JAPAN 145
- 14.1.4 INDONESIA 149
- 14.1.5 SOUTH KOREA 153
- 14.1.6 AUSTRALIA 157
- 14.1.7 THAILAND 161
- 14.1.8 VIETNAM 165
- 14.1.9 PHILIPPINES 169
- 14.1.10 MALAYSIA 173
- 14.1.11 SINGAPORE 177
- 14.1.12 REST OF ASIA- PACIFIC 181

15 ASIA PACIFIC PINGUECULUM DRUGS MARKET: COMPANY LANDSCAPE 182

15.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 182

16 SWOT ANALYSIS 183

17 COMPANY PROFILE 184

17.1 ALCON INC. 184
- 17.1.1 COMPANY SNAPSHOT 184
- 17.1.2 REVENUE ANALYSIS 184
- 17.1.3 COMPANY SHARE ANALYSIS 185
- 17.1.4 PRODUCT PORTFOLIO 185
- 17.1.5 RECENT DEVELOPMENT 185
17.2 ABBVIE INC. 186
- 17.2.1 COMPANY SNAPSHOT 186
- 17.2.2 REVENUE ANALYSIS 186
- 17.2.3 COMPANY SHARE ANALYSIS 187
- 17.2.4 PRODUCT PORTFOLIO 187
- 17.2.5 RECENT DEVELOPMENT 188
17.3 BAUSCH & LOMB INCORPORATED 189
- 17.3.1 COMPANY SNAPSHOT 189
- 17.3.2 REVENUE ANALYSIS 189
- 17.3.3 COMPANY SHARE ANALYSIS 190
- 17.3.4 PRODUCT PORTFOLIO 190
- 17.3.5 RECENT DEVELOPMENT 191
17.4 BAYER AG 192
- 17.4.1 COMPANY SNAPSHOT 192
- 17.4.2 REVENUE ANALYSIS 192
- 17.4.3 COMPANY SHARE ANALYSIS 193
- 17.4.4 PRODUCT PORTFOLIO 193
- 17.4.5 RECENT DEVELOPMENTS 193
17.5 JOHNSON & JOHNSON VISION CARE, INC. 194
- 17.5.1 COMPANY SNAPSHOT 194
- 17.5.2 REVENUE ANALYSIS 194
- 17.5.3 COMPANY SHARE ANALYSIS 195
- 17.5.4 PRODUCT PORTFOLIO 195
- 17.5.5 RECENT DEVELOPMENT 195
17.6 AKORN OPERATING COMPANY LLC 196
- 17.6.1 COMPANY SNAPSHOT 196
- 17.6.2 . PRODUCT PORTFOLIO 196
- 17.6.3 RECENT DEVELOPMENT 196
17.7 AMNEAL PHARMACEUTICALS LLC. 197
- 17.7.1 COMPANY SNAPSHOT 197
- 17.7.2 REVENUE ANALYSIS 197
- 17.7.3 PRODUCT PORTFOLIO 198
- 17.7.4 RECENT DEVELOPMENTS 198
17.8 EYERIS VISIONCARE PVT. LTD. 199
- 17.8.1 COMPANY SNAPSHOT 199
- 17.8.2 PRODUCT PORTFOLIO 199
- 17.8.3 RECENT DEVELOPMENTS 200
17.9 LABORATOIRES THEA 201
- 17.9.1 COMPANY SNAPSHOT 201
- 17.9.2 PRODUCT PORTFOLIO 201
- 17.9.3 RECENT DEVELOPMENT 202
17.10 MAYA BIOTECH PRIVATE LIMITED 203
- 17.10.1 COMPANY SNAPSHOT 203
- 17.10.2 PRODUCT PORTFOLIO 203
- 17.10.3 RECENT DEVELOPMENTS 204
17.11 NOVARTIS AG 205
- 17.11.1 COMPANY SNAPSHOT 205
- 17.11.2 REVENUE ANALYSIS 205
- 17.11.3 PRODUCT PORTFOLIO 206
- 17.11.4 RECENT DEVELOPMENT 206
17.12 OASIS MEDICAL, INC. 207
- 17.12.1 COMPANY SNAPSHOT 207
- 17.12.2 PRODUCT PORTFOLIO 207
- 17.12.3 RECENT DEVELOPMENT 207
17.13 PRESTIGE CONSUMER HEALTHCARE, INC. 208
- 17.13.1 COMPANY SNAPSHOT 208
- 17.13.2 PRODUCT PORTFOLIO 209
- 17.13.3 RECENT DEVELOPMENT 209
17.14 SAGER PHARMA 210
- 17.14.1 COMPANY SNAPSHOT 210
- 17.14.2 PRODUCT PORTFOLIO 210
- 17.14.3 RECENT DEVELOPMENTS 210
17.15 SANTEN PHARMACEUTICAL CO., LTD. 211
- 17.15.1 COMPANY SNAPSHOT 211
- 17.15.2 REVENUE ANALYSIS 211
- 17.15.3 PRODUCT PORTFOLIO 212
- 17.15.4 RECENT DEVELOPMENTS 212
17.16 SIMILASAN CORPORATION 213
- 17.16.1 COMPANY SNAPSHOT 213
- 17.16.2 PRODUCT PORTFOLIO 213
- 17.16.3 RECENT DEVELOPMENTS 213
17.17 SPECTRA VISION CARE 214
- 17.17.1 COMPANY SNAPSHOT 214
- 17.17.2 PRODUCT PORTFOLIO 214
- 17.17.3 RECENT DEVELOPMENTS 215
17.18 SYLENTIS 216
- 17.18.1 COMPANY SNAPSHOT 216
- 17.18.2 PRODUCT PORTFOLIO 216
- 17.18.3 RECENT DEVELOPMENTS 216
17.19 WELLONA PHARMA 217
- 17.19.1 COMPANY SNAPSHOT 217
- 17.19.2 PRODUCT PORTFOLIO 217
- 17.19.3 RECENT DEVELOPMENTS 217
17.20 ZYDUS GROUP 218
- 17.20.1 COMPANY SNAPSHOT 218
- 17.20.2 REVENUE ANALYSIS 218
- 17.20.3 PRODUCT PORTFOLIO 219
- 17.20.4 RECENT DEVELOPMENTS 219

18 QUESTIONNAIRE 220

19 RELATED REPORTS 224

LIST OF TABLES

TABLE 1 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 65
TABLE 2 ASIA PACIFIC ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 66
TABLE 3 ASIA PACIFIC ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 66
TABLE 4 ASIA PACIFIC STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 67
TABLE 5 ASIA PACIFIC STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 67
TABLE 6 ASIA PACIFIC KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 68
TABLE 7 ASIA PACIFIC NON-STEROIDAL ANTI-INFLAMMATORY DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 69
TABLE 8 ASIA PACIFIC OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 69
TABLE 9 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 73
TABLE 10 ASIA PACIFIC EYE DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 74
TABLE 11 ASIA PACIFIC EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 74
TABLE 12 ASIA PACIFIC EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 75
TABLE 13 ASIA PACIFIC EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 75
TABLE 14 ASIA PACIFIC OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 76
TABLE 15 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 80
TABLE 16 ASIA PACIFIC PRESCRIPTION IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 81
TABLE 17 ASIA PACIFIC OVER THE COUNTER (OTC) IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 81
TABLE 18 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 85
TABLE 19 ASIA PACIFIC BRANDED IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 86
TABLE 20 ASIA PACIFIC GENERICS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 86
TABLE 21 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 90
TABLE 22 ASIA PACIFIC GERIATRIC IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 91
TABLE 23 ASIA PACIFIC GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 91
TABLE 24 ASIA PACIFIC ADULTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 92
TABLE 25 ASIA PACIFIC ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 92
TABLE 26 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 96
TABLE 27 ASIA PACIFIC HOSPITALS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 97
TABLE 28 ASIA PACIFIC SPECIALTY CLINICS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 97
TABLE 29 ASIA PACIFIC HOME HEALTHCARE IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 98
TABLE 30 ASIA PACIFIC OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 98
TABLE 31 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 102
TABLE 32 ASIA PACIFIC RETAIL PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 103
TABLE 33 ASIA PACIFIC HOSPITAL PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 103
TABLE 34 ASIA PACIFIC ONLINE PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 104
TABLE 35 ASIA PACIFIC OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 104
TABLE 36 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 111
TABLE 37 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 111
TABLE 38 ASIA-PACIFIC ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 111
TABLE 39 ASIA-PACIFIC STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 112
TABLE 40 ASIA-PACIFIC KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 112
TABLE 41 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 112
TABLE 42 ASIA-PACIFIC EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 113
TABLE 43 ASIA-PACIFIC EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 113
TABLE 44 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 113
TABLE 45 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 113
TABLE 46 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 114
TABLE 47 ASIA-PACIFIC GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 114
TABLE 48 ASIA-PACIFIC ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 114
TABLE 49 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 114
TABLE 50 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 115
TABLE 51 CHINA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 116
TABLE 52 CHINA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 116
TABLE 53 CHINA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 116
TABLE 54 CHINA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 117
TABLE 55 CHINA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 117
TABLE 56 CHINA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 117
TABLE 57 CHINA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 118
TABLE 58 CHINA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 118
TABLE 59 CHINA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 118
TABLE 60 CHINA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 118
TABLE 61 CHINA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 119
TABLE 62 CHINA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 119
TABLE 63 CHINA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 119
TABLE 64 CHINA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 119
TABLE 65 INDIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 120
TABLE 66 INDIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 120
TABLE 67 INDIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 120
TABLE 68 INDIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 121
TABLE 69 INDIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 121
TABLE 70 INDIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 121
TABLE 71 INDIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 122
TABLE 72 INDIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 122
TABLE 73 INDIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 122
TABLE 74 INDIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 122
TABLE 75 INDIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 123
TABLE 76 INDIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 123
TABLE 77 INDIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 123
TABLE 78 INDIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 123
TABLE 79 JAPAN PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 124
TABLE 80 JAPAN ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 124
TABLE 81 JAPAN STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 124
TABLE 82 JAPAN KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 125
TABLE 83 JAPAN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 125
TABLE 84 JAPAN EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 125
TABLE 85 JAPAN EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 126
TABLE 86 JAPAN PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 126
TABLE 87 JAPAN PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 126
TABLE 88 JAPAN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 126
TABLE 89 JAPAN GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 127
TABLE 90 JAPAN ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 127
TABLE 91 JAPAN PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 127
TABLE 92 JAPAN PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 127
TABLE 93 INDONESIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 128
TABLE 94 INDONESIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 128
TABLE 95 INDONESIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 128
TABLE 96 INDONESIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 129
TABLE 97 INDONESIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 129
TABLE 98 INDONESIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 129
TABLE 99 INDONESIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 130
TABLE 100 INDONESIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 130
TABLE 101 INDONESIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 130
TABLE 102 INDONESIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 130
TABLE 103 INDONESIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 131
TABLE 104 INDONESIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 131
TABLE 105 INDONESIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 131
TABLE 106 INDONESIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 131
TABLE 107 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 132
TABLE 108 SOUTH KOREA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 132
TABLE 109 SOUTH KOREA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 132
TABLE 110 SOUTH KOREA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 133
TABLE 111 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 133
TABLE 112 SOUTH KOREA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 133
TABLE 113 SOUTH KOREA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 134
TABLE 114 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 134
TABLE 115 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 134
TABLE 116 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 134
TABLE 117 SOUTH KOREA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 135
TABLE 118 SOUTH KOREA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 135
TABLE 119 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 135
TABLE 120 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 135
TABLE 121 AUSTRALIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 136
TABLE 122 AUSTRALIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 136
TABLE 123 AUSTRALIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 136
TABLE 124 AUSTRALIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 137
TABLE 125 AUSTRALIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 137
TABLE 126 AUSTRALIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 137
TABLE 127 AUSTRALIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 138
TABLE 128 AUSTRALIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 138
TABLE 129 AUSTRALIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 138
TABLE 130 AUSTRALIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 138
TABLE 131 AUSTRALIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 139
TABLE 132 AUSTRALIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 139
TABLE 133 AUSTRALIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 139
TABLE 134 AUSTRALIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 139
TABLE 135 THAILAND PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 140
TABLE 136 THAILAND ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 140
TABLE 137 THAILAND STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 140
TABLE 138 THAILAND KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 141
TABLE 139 THAILAND PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 141
TABLE 140 THAILAND EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 141
TABLE 141 THAILAND EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 142
TABLE 142 THAILAND PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 142
TABLE 143 THAILAND PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 142
TABLE 144 THAILAND PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 142
TABLE 145 THAILAND GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 143
TABLE 146 THAILAND ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 143
TABLE 147 THAILAND PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 143

TABLE 148 THAILAND PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 143
TABLE 149 VIETNAM PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 144
TABLE 150 VIETNAM ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 144
TABLE 151 VIETNAM STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 144
TABLE 152 VIETNAM KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 145
TABLE 153 VIETNAM PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 145
TABLE 154 VIETNAM EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 145
TABLE 155 VIETNAM EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 146
TABLE 156 VIETNAM PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 146
TABLE 157 VIETNAM PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 146
TABLE 158 VIETNAM PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 146
TABLE 159 VIETNAM GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 147
TABLE 160 VIETNAM ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 147
TABLE 161 VIETNAM PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 147
TABLE 162 VIETNAM PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 147
TABLE 163 PHILIPPINES PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 148
TABLE 164 PHILIPPINES ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 148
TABLE 165 PHILIPPINES STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 148
TABLE 166 PHILIPPINES KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 149
TABLE 167 PHILIPPINES PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 149
TABLE 168 PHILIPPINES EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 149
TABLE 169 PHILIPPINES EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 150
TABLE 170 PHILIPPINES PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 150
TABLE 171 PHILIPPINES PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 150
TABLE 172 PHILIPPINES PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 150
TABLE 173 PHILIPPINES GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 151
TABLE 174 PHILIPPINES ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 151
TABLE 175 PHILIPPINES PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 151
TABLE 176 PHILIPPINES PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 151
TABLE 177 MALAYSIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 152
TABLE 178 MALAYSIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 152
TABLE 179 MALAYSIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 152
TABLE 180 MALAYSIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 153
TABLE 181 MALAYSIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 153
TABLE 182 MALAYSIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 153
TABLE 183 MALAYSIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 154
TABLE 184 MALAYSIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 154
TABLE 185 MALAYSIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 154
TABLE 186 MALAYSIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 154
TABLE 187 MALAYSIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 155
TABLE 188 MALAYSIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 155
TABLE 189 MALAYSIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 155
TABLE 190 MALAYSIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 155
TABLE 191 SINGAPORE PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 156
TABLE 192 SINGAPORE ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 156
TABLE 193 SINGAPORE STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 156
TABLE 194 SINGAPORE KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 157
TABLE 195 SINGAPORE PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 157
TABLE 196 SINGAPORE EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 157
TABLE 197 SINGAPORE EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 158
TABLE 198 SINGAPORE PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 158
TABLE 199 SINGAPORE PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 158
TABLE 200 SINGAPORE PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 158
TABLE 201 SINGAPORE GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 159
TABLE 202 SINGAPORE ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 159
TABLE 203 SINGAPORE PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 159
TABLE 204 SINGAPORE PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 159
TABLE 205 REST OF ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 160

LIST OF FIGURES

FIGURE 1 ASIA PACIFIC PINGUECULUM DRUGS MARKET: SEGMENTATION 26
FIGURE 2 ASIA PACIFIC PINGUECULUM DRUGS MARKET: DATA TRIANGULATION 29
FIGURE 3 ASIA PACIFIC PINGUECULUM DRUGS MARKET: DROC ANALYSIS 30
FIGURE 4 ASIA PACIFIC PINGUECULUM DRUGS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS 31
FIGURE 5 ASIA PACIFIC PINGUECULUM DRUGS MARKET: COMPANY RESEARCH ANALYSIS 31
FIGURE 6 ASIA PACIFIC PINGUECULUM DRUGS MARKET: INTERVIEW DEMOGRAPHICS 32
FIGURE 7 ASIA PACIFIC PINGUECULUM DRUGS MARKET: DBMR POSITION GRID 34
FIGURE 8 ASIA PACIFIC PINGUECULUM DRUGS MARKET: VENDOR SHARE ANALYSIS 36
FIGURE 9 ASIA PACIFIC PINGUECULUM DRUGS MARKET: END USER COVERAGE GRID 37
FIGURE 10 ASIA PACIFIC PINGUECULUM DRUGS MARKET: SEGMENTATION 41
FIGURE 11 INCREASING PREVALENCE OF OPHTHALMIC DISORDERS AND THE RISE IN THE GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE ASIA PACIFIC PINGUECULUM DRUGS MARKET GROWTH FROM 2022 TO 2029 42
FIGURE 12 ARTIFICIAL TEARS/TOPICAL LUBRICANTS SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE ASIA PACIFIC PINGUECULUM DRUGS MARKET FROM 2022 & 2029 42
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC PINGUECULUM DRUGS MARKET 52
FIGURE 14 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY TREATMENT, 2021 62
FIGURE 15 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY TREATMENT, 2022-2029 (USD MILLION) 63
FIGURE 16 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY TREATMENT, CAGR (2022-2029) 63
FIGURE 17 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY TREATMENT, LIFELINE CURVE 64
FIGURE 18 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY FORMULATION, 2021 70
FIGURE 19 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY FORMULATION, 2022-2029 (USD MILLION) 71
FIGURE 20 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY FORMULATION, CAGR (2022-2029) 71
FIGURE 21 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY FORMULATION, LIFELINE CURVE 72
FIGURE 22 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, 2021 77
FIGURE 23 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, 2022-2029 (USD MILLION) 78
FIGURE 24 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, CAGR (2022-2029) 78
FIGURE 25 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, LIFELINE CURVE 79
FIGURE 26 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, 2021 82
FIGURE 27 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, 2022-2029 (USD MILLION) 83
FIGURE 28 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, CAGR (2022-2029) 83
FIGURE 29 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, LIFELINE CURVE 84
FIGURE 30 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, 2021 87
FIGURE 31 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, 2022-2029 (USD MILLION) 88
FIGURE 32 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, CAGR (2022-2029) 88
FIGURE 33 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, LIFELINE CURVE 89
FIGURE 34 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY END USER, 2021 93
FIGURE 35 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY END USER, 2022-2029 (USD MILLION) 94
FIGURE 36 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY END USER, CAGR (2022-2029) 94
FIGURE 37 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY END USER, LIFELINE CURVE 95
FIGURE 38 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2021 99
FIGURE 39 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION) 100
FIGURE 40 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029) 100
FIGURE 41 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 101
FIGURE 42 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: SNAPSHOT (2021) 106
FIGURE 43 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: BY COUNTRY (2021) 108
FIGURE 44 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: BY COUNTRY (2022 & 2029) 108
FIGURE 45 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: BY COUNTRY (2021 & 2029) 109
FIGURE 46 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: BY TREATMENT (2022-2029) 109
FIGURE 47 ASIA PACIFIC PINGUECULUM DRUGS MARKET: COMPANY SHARE 2021 (%) 160